Lobbying firm

BIOMARIN PHARMACEUTICAL INC.

Develops and commercializes biopharmaceuticals.

Filings
58
Clients
1
Total income
—
Lobbyists
4
Years active
2013–2026

Filings counts every document on the register, amendments included. Income is the fees reported to clients, counting the current version of each report once.

Income by year

Fees reported, $ thousands 2013 to 2026

Filings

58 filings, newest first.
Filing Client Income Expenses
3rd Quarter - Report
3rd Quarter 2026
BIOMARIN PHARMACEUTICAL INC. — income $200,000 expenses
2nd Quarter - Amendment
2nd Quarter 2026
BIOMARIN PHARMACEUTICAL INC. — income $340,000 expenses
2nd Quarter - Amendmentreplaced
2nd Quarter 2026
BIOMARIN PHARMACEUTICAL INC. — income $340,000 expenses
2nd Quarter - Reportreplaced
2nd Quarter 2026
BIOMARIN PHARMACEUTICAL INC. — income $340,000 expenses
1st Quarter - Report
1st Quarter 2026
BIOMARIN PHARMACEUTICAL INC. — income $530,000 expenses
4th Quarter - Report
4th Quarter 2025
BIOMARIN PHARMACEUTICAL INC. — income $390,000 expenses
3rd Quarter - Report
3rd Quarter 2025
BIOMARIN PHARMACEUTICAL INC. — income $270,000 expenses
2nd Quarter - Report
2nd Quarter 2025
BIOMARIN PHARMACEUTICAL INC. — income $270,000 expenses
1st Quarter - Report
1st Quarter 2025
BIOMARIN PHARMACEUTICAL INC. — income $390,000 expenses
4th Quarter - Report
4th Quarter 2024
BIOMARIN PHARMACEUTICAL INC. — income $490,000 expenses

Clients

Everyone this filer has reported for, with the reports filed and the income they disclose.

ClientReportsIncome
BIOMARIN PHARMACEUTICAL INC. 54 —

Lobbyists

Everyone named on this filer's reports, with the government post they most recently disclosed here.

LobbyistCovered position, as disclosed
TERICKE BLANCHARD N/A
JOHN EDWARD GREISSING N/A
KATHRYN LOWELL N/A
DANIEL MAYNE SENIOR REGULATORY HEALTH CONSULTANT- FOOD & DRUG ADMINISTRATION (6/2020-2/2022); REGULATORY POLICY ANALYST- FOOD & DRUG ADMINISTRATION (9/2023-6/2024)

From reports filed under the Lobbying Disclosure Act. A firm reports income from each client; an organisation lobbying for itself reports its own expenses instead. Each figure links to the filing it comes from.